News and Updates

Omnipod® producer Insulet announced today that it would expand its financial assistance program to those U.S. customers who had lost insurance in the wake of changes due to the coronavirus pandemic. For those who qualify, the company will provide a six-month supply (60 Pods) of product for free. Those customers who might benefit must meet […]

Today, leading insulin manufacturer Novo Nordisk announced that it would offer 90 days of free insulin to those who lost their jobs and medical insurance because of the coronavirus pandemic. The announcement comes just days after Eli Lilly and Company announced that it would provide a co-pay card letting anyone with or without commercial insurance […]

Quite quickly, the coronavirus pandemic has disrupted daily life, jolted perspectives and could very well change how we work and interact with each other for a long time to come. But what has the impact been inside research labs, where Breakthrough T1D-funded scientists have been driving hard and fast to deliver cures for type 1 […]

Dr. Aaron J. Kowalski answers what the pandemic means to ongoing research and fundraising and why “there still are no cures” for type 1 diabetes.

Games, activities, crafts, and virtual voyages to keep the family entertained and active during this time of social distancing.

Several decades ago, type 1 diabetes (T1D) patients brought their seeing-eye dogs into the offices where Jennifer Sun, M.D., MPH., now works. The complications of T1D had severely compromised or cost the patients their eyesight. Today, work led by Dr. Sun is changing all that. We share Dr. Sun’s work as part of our Meet […]

I’ve just gotten back from the 12th Network for Pancreatic Organ Donors with Diabetes (nPOD) Annual Meeting, which was held February 23-26, 2020, and featured some of the most world-renowned diabetes investigators. nPOD is now the world’s largest tissue bank dedicated to the study of the human pancreas in type 1 diabetes (T1D), and the […]

The Breakthrough T1D International Board of Directors (IBOD) named two long-time volunteers to serve as Chair and Vice Chair when current board leaders end their two-year terms on July 1. Joseph P. Lacher, Jr., who is President and Chief Executive Officer of Kemper Corporation, will serve as Breakthrough T1D Chair, succeeding current Chair Ellen Leake. […]

Each year diabetes researchers from all over the world gather for the annual meeting of the Advanced Technologies & Treatments for Diabetes (ATTD), which this year took place on February 19-22 in Madrid, Spain. Many of the latest advances will be discussed, including research that Breakthrough T1D has funded to advance new breakthroughs and therapies […]